Last reviewed · How we verify
SCB-1033
At a glance
| Generic name | SCB-1033 |
|---|---|
| Sponsor | Clover Biopharmaceuticals AUS Pty |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |